NCT04857710

Brief Summary

Neuromuscular electrostimulation (NMES) is a technique used in the clinical and training fields to increase the strength of a muscle group.The recent use of wide-pulse (WP) stimulations allows, in addition to the direct activation of the muscle fibers, the use of sensory pathways. This more global solicitation of the neuromuscular system (i.e. information going back to the spinal cord and even to the brain) prejudges more nervous adaptations and therefore a greater functional benefit. The first aim of this study is to evaluate and compare the force gains induced by 2 NMES training programs (CONV, WP) applied on knee extensors in healthy subjects for 6 weeks.The second aim is to understand the neuromuscular adaptations involved in these gains, as well as the functional benefit resulting from these improvements.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P50-P75 for not_applicable healthy-volunteers

Timeline
Completed

Started May 2021

Typical duration for not_applicable healthy-volunteers

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 20, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 23, 2021

Completed
12 days until next milestone

Study Start

First participant enrolled

May 5, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 9, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 22, 2022

Completed
Last Updated

September 14, 2022

Status Verified

September 1, 2022

Enrollment Period

1 year

First QC Date

April 20, 2021

Last Update Submit

September 12, 2022

Conditions

Keywords

Wide-pulseTrainingStrength gainNeuromuscular adaptationsNeuromuscular electrostimulation

Outcome Measures

Primary Outcomes (1)

  • Maximal voluntary contraction (MVC) of the knee extensor muscle measurement

    Maximal isometric force (maximal voluntary contraction, MVC) of the knee extensor muscle

    week 6

Secondary Outcomes (12)

  • Voluntary activation measurement (%)

    week 6

  • Voluntary activation measurement (%)

    week 12

  • Cortico-spinal excitability measurement

    week 6

  • Cortico-spinal excitability measurement

    week 12

  • Spinal excitability measurement

    week 6

  • +7 more secondary outcomes

Study Arms (3)

Control (CONT)

ACTIVE COMPARATOR

A control (CONT) modality is used as a reference and is representative of a sedentary behaviour regularly observed in our populations

Device: Control (CONT) modality

Conventional neuromuscular electrostimulation (CONV)

EXPERIMENTAL

The CONV (conventional) modality allows us to compare with the current clinical application and the majority of the literature on the adaptations induced by NMES (neuromuscular electrostimulation) training.

Device: Conventional neuromuscular electrostimulation (CONV NMES)

Wide-pulse neuromuscular electrostimulation (WP)

EXPERIMENTAL

The use of wide-pulse (WP) stimulations allows, in addition to the direct activation of the muscle fibers, the use of sensory pathways. This more global solicitation of the neuromuscular system (i.e. information going back to the spinal cord and even to the brain) prejudges more nervous adaptations and therefore a greater functional benefit.

Device: Wide-pulse neuromuscular electrostimulation (WP NMES)

Interventions

The WP NMES program consists of electrical stimulation trains of 1000 symmetrical biphasic pulses (1 ms, 100 Hz). The duration of a train is of 10 s and the rest between trains is of 30 s. A WP NMES session includes 30 evoked contractions. The stimulation intensity is monitored online and adjusted to the highest tolerable by the subjects.During the stimulation, subjects are seated with the knee joint fixed a 60° angle. Three self-adhesive electrodes are placed over the right thigh. The positive electrodes, measuring 25 cm² (5 x 5 cm), are placed as close as possible to the motor point of the vastus lateralis and vastus medialis muscles. The negative electrode, measuring 50 cm² (10 x 5 cm), is placed 5-7 cm below the inguinal ligament. Electrical stimulations are delivered by a stimulator BioStim (Mazet Santé).

Wide-pulse neuromuscular electrostimulation (WP)

The CONV NMES program consists of electrical stimulation trains of 500 symmetrical biphasic pulses (0.2 ms, 50 Hz). The duration of a train is of 10 s and the rest between trains is of 30 s (duty cycle: 1/3). A WP NMES session includes 30 evoked contractions. The stimulation intensity is monitored online and adjusted to the highest tolerable by the subjects. During the stimulation, subjects are seated with the knee joint fixed a 60° angle. Three self-adhesive electrodes are placed over the right thigh. The positive electrodes, measuring 25 cm² (5 x 5 cm), are placed as close as possible to the motor point of the vastus lateralis and vastus medialis muscles. The negative electrode, measuring 50 cm² (10 x 5 cm), is placed 5-7 cm below the inguinal ligament. Electrical stimulations are delivered by a stimulator BioStim (Mazet Santé).

Conventional neuromuscular electrostimulation (CONV)

Control (CONT) modality is used as a reference and is representative of a sedentary behaviour regularly observed in our populations.

Control (CONT)

Eligibility Criteria

Age18 Years - 50 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Affiliates or beneficiaries of a social security scheme
  • Having freely given their written consent

You may not qualify if:

  • Disease or surgery resulting in a locomotor disorder, within 6 months prior to the study
  • Chronic neurological, motor or psychic diseases
  • Taking neuro-active substances likely to alter cortico-spinal excitability (hypnotics, antiepileptics, psychotropic drugs, muscle relaxants) for the duration of the study
  • Contraindication to neuromuscular electrostimulation
  • Contraindication to magnetic stimulation
  • Participation at the same time in another interventional experiment or having participated in such a study within 30 days prior to this study
  • Sports (\>10 hours per week or strength training of the lower limbs)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Saint-Etienne

Saint-Etienne, 42000, France

Location

Study Officials

  • Léonard FEASSON, MD PHD

    Centre Hospitalier de Saint-Etienne

    PRINCIPAL INVESTIGATOR
  • Thomas LAPOLE, PhD

    Université de Saint-Etienne

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Evaluating and comparing the force gains induced by 2 NMES training programs (CONV, WP) applied on knee extensors in healthy subjects for 6 weeks. Understanding the neuromuscular adaptations involved in these gains, as well as the functional benefit resulting from these improvements. To consolidate the benefit of NMES programs, a control (CONT) modality is used as a reference and is representative of a sedentary behaviour regularly observed in our populations. The CONV modality allows us to compare with the current clinical application and the majority of the literature on the adaptations induced by NMES training. Finally, the WP modality aims to assess the possible benefits linked to the use of wide-pulses during the application of NMES.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 20, 2021

First Posted

April 23, 2021

Study Start

May 5, 2021

Primary Completion

May 9, 2022

Study Completion

August 22, 2022

Last Updated

September 14, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations